| FASPX | VMVIX | FASPX / VMVIX | |
| Total Expense Ratio | 1.34 | 0.19 | 705% |
| Annual Report Gross Expense Ratio | 1.34 | 0.19 | 705% |
| Fund Existence | 39 years | 19 years | - |
| Gain YTD | 9.378 | 10.973 | 85% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.7B | 32.6B | 5% |
| Annual Yield % from dividends | 0.38 | 2.02 | 19% |
| Returns for 1 year | -2.16 | 9.73 | -22% |
| Returns for 3 years | 23.41 | 33.21 | 70% |
| Returns for 5 years | 42.12 | 53.81 | 78% |
| Returns for 10 years | 34.34 | 110.07 | 31% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SPVU | 57.36 | 0.27 | +0.48% |
| Invesco S&P 500® Enhanced Value ETF | |||
| NBB | 15.74 | 0.07 | +0.45% |
| Nuveen Taxable Municipal Income Fund | |||
| RJMG | 27.53 | 0.09 | +0.33% |
| FT Raymond James Multcp Gr Eq ETF | |||
| IHI | 62.73 | 0.09 | +0.14% |
| iShares US Medical Devices ETF | |||
| FEBU | 27.93 | N/A | N/A |
| AllianzIM U.S. Equity Buffer15 UncFebETF | |||